Acumen Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-43.1M | $-43.1M | $21.0K | $6.1M |
| FY2024 | $-86.2M | $-86.2M | $16.0K | $9.6M |
| FY2025 | $-115.5M | $-115.6M | $88.0K | $9.9M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-43.1M | $-43.1M | $21.0K | $6.1M |
| FY2024 | $-86.2M | $-86.2M | $16.0K | $9.6M |
| FY2025 | $-115.5M | $-115.6M | $88.0K | $9.9M |